Mepilex Ag: an antimicrobial, absorbent foam dressing with Safetac technology.
This article examines the role of a unique dressing-Mepilex Ag--that incorporates the rapid and sustained antimicrobial action of ionic silver with the benefits of Safetac soft silicone adhesive technology. The combined attributes of each component of this dressing allow both the control of pain and infection to be achieved simultaneously. This dual approach to the management of wounds is of significance since the evidence suggests that wound infection and the release of pro-inflammatory modulators result in both local pain and delayed healing. In this respect the control and treatment of pain is as important as the treatment of infection itself. A review of the clinical evidence relating to Safetac technology clearly demonstrates that it can be used to prevent dressing-related trauma, minimize pain at dressing change, and control exudate when used on a wide range of wound types and skin injuries. In combination with silver, this technology has been shown in in-vitro studies to have an almost instant and sustainable antimicrobial effect on a broad range of pathogens associated with delayed healing. Finally, in small clinical and case studies, Mepilex Ag has been shown to control wound bioburden and improve healing rates.
Barrett
Simon
S
Tissue Viability, NHS East Riding of Yorkshire Primary Care Trust, Yorkshire.
D000269:Adhesives / Q000627:therapeutic use; D000369:Aged, 80 and over; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001458:Bandages / Q000592:standards; D002908:Chronic Disease; D005122:Exudates and Transudates; D006801:Humans; D017053:Infection Control; D008297:Male; D012828:Silicones; D018030:Silver Compounds / Q000627:therapeutic use*; D017592:Skin Care / Q000295:instrumentation*; D016896:Treatment Outcome; D014945:Wound Healing; D014946:Wound Infection / Q000517:prevention & control*
D000269:Adhesives; D000891:Anti-Infective Agents, Local; D012828:Silicones; D018030:Silver Compounds